Effect of Spironolactone on 30 Day Readmission Rates in Patients with Heart Failure Following Ultrafiltration Therapy
| Autor: | Mahesh Aradhya, Deepakraj Gajanana, Hyma Vani Polimera, Ellen Amedeo, Santh V.S. Silpershetty, Prasanna Sugathan |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
High rate
education.field_of_study medicine.medical_specialty business.industry medicine.medical_treatment Population Revascularization medicine.disease Angina chemistry.chemical_compound chemistry Internal medicine Heart failure medicine Cardiology Spironolactone In patient cardiovascular diseases Cardiology and Cardiovascular Medicine business education Medical therapy |
| Zdroj: | Journal of Cardiac Failure. 17:S82 |
| ISSN: | 1071-9164 |
| Popis: | anti-platelets, statins and beta-blockers. Symptomatic patients had similarly high event rates for mortality, NFMI and rehospitalization compared to those without angina (Table 2). Conclusion: In patients with ICM, angina is common despite medical therapy and previous revascularization and is associated with high rates of fatal and non-fatal events, which are similar to those of patients without angina. There is a need for therapies to reduce angina and events in this high risk population. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect